Gene therapy for lung inflammatory diseases: Not so far away?

Thorax

Volumn 52, Issue 8, 1997, Pages 742-744

  Sallenave, Jean Michel ^a   Porteous, David J ^b   Haslett, Christopher ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adenovirus; Elastase; Elastase inhibitors; Gene therapy; Liposomes

Indexed keywords

ELASTASE; ELASTASE INHIBITOR; LIPOSOME; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CYSTIC FIBROSIS; DOSE RESPONSE; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PNEUMONIA; PRIORITY JOURNAL; TISSUE SPECIFICITY; TRANSGENE;

EID: 0030882631     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.8.742     Document Type: Article

References (12)

1. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 1994;8:42-51.
2. Caplen NJ, Alton EWFW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995;1:3946.
3. Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997;4:210-8.
4. Curiel DT, Pilewski JM, Abelda, SM. Gene therapy approaches for inherited and acquired lung diseases. Am J Respir Cell Mol Biol 1996;14:1-18.
5. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995;9:190-9.
6. Bramson JL, Graham FL, Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol 1995;6:590-5.
7. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson J. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996;217:11-22.
8. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995;1:890-3.
9. Kay MA, Holterman AX, Mense L, Gown A, Ochs, HD, Linsley PS, et al. Long term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet 1995;11:191-7.
10. Yang Y, Su Q, Grewal IS, Schilz R, Flavell RA, Wilson JM. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996;70:6370-7.
11. Cox G. Interleukin-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol (Lung Cell Mol Physiol) 1996;271: L566-71.
12. Sallenave JM, Schulman J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994;11:733-41.